The validity of the neuropathic pain scale for assessing diabetic neuropathic pain in a clinical trial

Clinical Journal of Pain

Volumn 22, Issue 1, 2006, Pages 97-103

  Jensen, Mark P ^a   Friedman, Michael ^b   Bonzo, Daniel ^b   Richards, Patricia ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b PURDUE PHARMA L P   (United States)

Author keywords

Diabetic neuropathy; Neuropathic pain; Neuropathic Pain Scale; Pain assessment

Indexed keywords

ANALGESIC AGENT; OPIATE; OXYCODONE; PLACEBO; NARCOTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG EFFECT; DRUG FORMULATION; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN ASSESSMENT; PRIORITY JOURNAL; VALIDITY; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; MIDDLE AGED; MULTICENTER STUDY; PAIN THRESHOLD; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NARCOTICS; OXYCODONE; PAIN MEASUREMENT; PAIN THRESHOLD; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 33644919442     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ajp.0000173018.64741.62     Document Type: Article

References (25)

1. Turk DC, Okifuji A. Pain terms and taxonomies of pain. In: Loeser JD, Butler SH, Chapman CR, Turk DC, eds. Bonica's Management of Pain, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001:17-25.
2. Bennett GJ. Neuropathic pain, new insights, new interventions. Hosp Pract. 1998;33:95-98;101-114.
3. Max MB. Neuropathic pain syndromes. In: Max M, Portenoy R, Laska E, eds. Advances in Pain Research and Therapy, Vol. 18. New York: Raven Press, 1991:193-219.
4. Fields HL, Rowbotham MC. Multiple mechanisms of neuropathic pain: a clinical perspective. In: Gebhart GF, Hammond DL, Jensen TS, eds. Proceedings of the 7th World Congress on Pain. Seattle: IASP Press, 1994:437-454.
5. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract. 2000;47:123-128.
6. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology. 2000;55:915-920.
7. Chan AW, Macfarlane IA, Bowsher D, et al. Chronic pain in patients with diabetes mellitus: comparison with a non-diabetic population. Pain Clin. 1990;3:147-159.
8. Ziegler D, Gries FA, Spuler M, et al. The epidemiology of diabetic neuropathy. J Diabetes Complications. 1992;6:49-57.
9. Eisenberg E, Lurie Y, Braker C, et al. Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study. Neurology. 2001;57:505-509.
10. Goldstein DJ, Wang O, Gitter BD, et al. Dose-response study of the analgesic effect of lanepitant in patients with painful diabetic neuropathy. Clin Neuropharmacol. 2001;24:16-22.
11. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50:1842-1846.
12. Morello CM, Leckband SG, Stoner CP, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med. 1999;159:1931-1937.
13. Wallace MS, Rowbotham MC, Katz NP, et al. A randomized double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain. Neurology. 2002;59:1694-1700.
14. Watson CPN, Moulin D, Watt-Watson J, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003;105:71-78.
15. Kocher DK, Rawat N, Agrawal RP, et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo controlled study. Q J Med. 2004;97:33-38.
16. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 1997;48:332-338.
17. Gimbel J, Richards P, Portenoy R. Controlled-release oxycodone for pain in diabetic neuropathy. A randomized controlled trial. Neurology. 2003;60:927-934.
18. Raffa RB, Friderichs E, Reimann W, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther. 1992;260:275-285.
19. Sindrup SH, Andersen G, Madsen C, et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomized, double-blind, controlled trial. Pain. 1999;83:85-90.
20. Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 1998;50:1837-1841.
21. Jensen MP, Chen C, Brugger AM. Interpretation of Visual Analog Scale ratings and change scores: a reanalysis of two clinical trials of post-operative pain. J Pain. 2003;4:407-414.
22. Farrar JT, Young JP Jr, Lamoreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-158.
23. Farrar JT, Portenoy RK, Berlin JA, et al. Defining the clinically important difference in pain outcome measures. Pain. 2000;88:287-294.
24. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage. 2003;25:406-411.
25. Rowbotham MC. What is a 'clinically meaningful' reduction in pain? Pain. 2001;94:131-132.